CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Hu JM, Liu K, Liu JH, Jiang XL, Wang XL, Chen YZ, Li SG, Zou H, Pang LJ, Liu CX, Cui XB, Yang L, Zhao J, Shen XH, Jiang JF, Liang WH, Yuan XL, Li F.
Hu JM, et al. Among authors: li f, li sg.
Oncotarget. 2017 Mar 28;8(13):21526-21538. doi: 10.18632/oncotarget.15630.
Oncotarget. 2017.
PMID: 28423526
Free PMC article.